Twin to Twin Transfusion Syndrome

Twin to Twin Transfusion services offered in Chicago, IL

Some pregnancies require more advanced care, including those shaped by a condition called twin-to-twin transfusion. Treating this condition is one of many services available from Dr. Suwan Mehra, MD, who serves Chicago, Illinois and the Tri-state area.  Contact Dr. Mehra’s office if you’d like more information about this condition and the treatment options available. 

What is Twin-to-Twin transfusion Syndrome?

Twin-to-Twin Transfusion Syndrome (TTTS)

Twin-to-Twin Transfusion Syndrome (TTTS) is a serious condition that can occur in identical twins—or higher-order multiples—who share a single placenta, a situation known as a monochorionic pregnancy. While all identical twins share a placenta, only about 10 to 15 percent will develop TTTS. This condition does not affect fraternal twins, who each have their own placenta.

In a shared placenta, the babies are connected by small blood vessels. In most cases, blood flow between the twins is balanced, allowing both babies to grow and thrive. However, in TTTS, this balance is disrupted. One baby (the “donor” twin) transfers blood to the other (the “recipient” twin), creating a mismatch. As a result, the donor twin may become dehydrated and produce little or no urine, leading to a low amount of amniotic fluid. In contrast, the recipient twin can become overloaded with blood, producing too much urine and accumulating excessive amniotic fluid.

Without treatment, TTTS can pose serious health risks to both babies. The donor twin may experience slowed growth, while the recipient twin is at risk of heart complications due to the extra blood volume. Prompt diagnosis and intervention are essential, and advanced fetal therapies—including minimally invasive laser surgery—can significantly improve outcomes.

Twin Anemia-Polycythemia Sequence (TAPS)

In some cases, a milder but related condition called Twin Anemia-Polycythemia Sequence (TAPS) may occur. This happens when only red blood cells—not fluid—are exchanged through tiny, narrow vessel connections in the placenta. Over time, one baby becomes anemic (with too few red blood cells), while the other develops polycythemia (an excess of red blood cells, causing the blood to become thick). Unlike classic TTTS, amniotic fluid levels in TAPS typically remain normal, making diagnosis more challenging and reliant on specialized Doppler ultrasound assessments.

What causes Twin-to-Twin Transfusion Syndrome?

The placenta is a remarkable organ that nourishes and supports babies throughout pregnancy, delivering oxygen and vital nutrients as they grow. In pregnancies where twins share a single placenta, they are also connected by shared blood vessels within that placenta. While the exact cause of Twin-to-Twin Transfusion Syndrome (TTTS) is not fully understood, we know that sometimes the normal pattern of blood flow between these shared vessels becomes unbalanced.

When this happens, one baby begins to receive more blood than the other. The baby receiving too little blood may become growth-restricted and develop low amniotic fluid, while the baby receiving too much is at risk of heart strain and excess fluid. This uneven circulation is what leads to TTTS. It’s not caused by anything a parent did or didn’t do, and it can develop without warning—making early diagnosis and expert monitoring critically important.

How is Twin-to-Twin Transfusion Syndrome diagnosed?

TTTS is diagnosed through ultrasound, which allows us to monitor the babies’ growth, amniotic fluid levels, and blood flow in real time. A key sign of TTTS is an imbalance in amniotic fluid—where one baby has too much fluid and the other has too little. In some cases, changes in blood flow patterns within the umbilical cords or fetal hearts may also be seen.

Pregnant individuals may also notice symptoms such as a sudden or rapid increase in abdominal size, which can signal excessive amniotic fluid around one baby.

Because TTTS can progress quickly, early and frequent monitoring is essential. For pregnancies where twins share a placenta (monochorionic), we recommend ultrasounds every two weeks starting at 16 weeks’ gestation. In the third trimester, the frequency of ultrasounds often increases to ensure that any changes are detected and addressed promptly.

With careful monitoring and timely diagnosis, families can feel empowered and supported in making the best decisions for their babies.

What can be done to treat Twin-to-Twin Transfusion Syndrome?

Early diagnosis and timely intervention are essential in managing Twin-to-Twin Transfusion Syndrome (TTTS). The best treatment approach depends on how far along the pregnancy is and the stage of TTTS at the time of diagnosis. Dr. Mehra and his team will guide you through all available options with compassion and clarity, helping you understand what’s best for your babies in your unique situation. Common treatment options include:

Expectant Management

For early or milder cases—particularly Stage 1 TTTS—careful monitoring may be the best course. This includes frequent ultrasounds to closely watch the babies’ growth, fluid levels, and heart function. Many families continue their pregnancies safely under this watchful approach.

Amnioreduction

In some cases, fluid builds up too quickly in the sac surrounding the recipient twin. Amnioreduction is a procedure to gently remove this excess fluid using a thin needle guided by ultrasound—similar to an amniocentesis. This can help relieve pressure and improve the baby’s condition. Amnioreduction is sometimes used in early-stage TTTS or when diagnosis occurs later in pregnancy, beyond the window for laser treatment.

Fetoscopic Laser Photocoagulation

This minimally invasive surgery is considered the most effective treatment for advanced TTTS. Using a small camera called a fetoscope, the surgeon locates and seals the abnormal blood vessel connections in the shared placenta using a laser. This restores balanced circulation between the babies. The procedure is performed under ultrasound guidance and requires a highly skilled fetal surgery team.

Early Delivery

If TTTS is diagnosed later in pregnancy—typically in the third trimester—it may be safest to deliver the babies rather than attempt in-utero treatment. The timing of delivery depends on the severity of the condition and the gestational age, with a focus on optimizing outcomes for both babies.

How Is Twin-to-Twin Transfusion Syndrome (TTTS) Treated After Birth?

Because TTTS often leads to early delivery, many affected babies are born prematurely. While every effort is made to prolong the pregnancy safely, babies treated with laser ablation are typically born around 31 to 32 weeks’ gestation. Dr. Mehra and his team work closely with families to develop a personalized care plan aimed at giving each baby the best possible start in life.
We strongly recommend that delivery take place at a specialized mother-baby center with immediate access to high-level neonatal care. At our partnering hospitals, labor and delivery units are located just steps away from advanced neonatal intensive care units (NICUs), ensuring a seamless transition from birth to specialized newborn support. This close proximity allows the same physicians and care teams who guided you through treatment during pregnancy to be present at delivery—ready to provide immediate, coordinated care for your babies.
Our goal is to support your family every step of the way—from diagnosis and treatment through birth and beyond—with expertise, compassion, and continuity of care.

What Is the Long-Term Prognosis for My Babies?

The long-term outlook for babies affected by Twin-to-Twin Transfusion Syndrome (TTTS) depends on how early the condition is diagnosed and treated, as well as how far along the pregnancy is at the time of delivery. Generally, the sooner treatment is provided—and the longer the babies remain safely in the womb—the better their chances for a healthy outcome.

Without treatment, advanced TTTS carries a high risk of complications, and survival rates are low. However, with timely intervention—particularly fetoscopic laser surgery—those outcomes improve significantly. In nearly 90% of treated pregnancies, at least one baby survives and thrives after birth. In high-volume fetal therapy centers across the country, both twins survive in approximately 70% of treated cases.

Every pregnancy is unique, and while these statistics provide important context, Dr. Mehra and his team focus on the individual needs of each family. We are here to guide you with clear information, honest expectations, and unwavering support—every step of the way.

Will My Baby Require Long-Term Follow-Up?

Because Twin-to-Twin Transfusion Syndrome (TTTS) can affect multiple organ systems and development, long-term follow-up is often an important part of your babies’ care. Even after a successful treatment and delivery, continued monitoring helps ensure that any potential challenges are identified early and managed proactively.

Your babies will be supported by a dedicated team of specialists who understand the unique needs of children affected by TTTS. This care team typically includes a pediatrician who coordinates overall care, as well as pediatric cardiologists, developmental specialists, and other experts as needed. Together, they’ll work closely with your family to create a personalized follow-up plan tailored to your babies’ specific health and developmental needs.

Our goal is not only to treat TTTS before birth, but to support your family through every chapter that follows—with thoughtful, coordinated care and a long-term commitment to your children’s well-being.

Accessibility Toolbar